Autosomal dominant tubulointerstitial kidney disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Oct 2025M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

EMD Serono Research & Development Institute, Inc. — PHASE1

TrialRECRUITING
Mar 2025Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions

PepsiCo Global R&D — NA

TrialRECRUITING
Jan 2024EXOME SEQUENCING IN MEDULLARY SPONGE KIDNEY

Hospices Civils de Lyon

TrialACTIVE NOT RECRUITING
May 2020Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease

National Taiwan University Hospital — NA

TrialRECRUITING
Feb 2016Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies

Imagine Institute — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Epogen

Amgen, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Epogen

(Epoetin alfa)Orphan drugstandard

Amgen, Inc.

12.1 Mechanism of Action Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

2 active trials
2N/A
2Total recruiting
Search clinical trials for Autosomal dominant tubulointerstitial kidney disease

Recent News & Research

No recent news articles indexed yet for Autosomal dominant tubulointerstitial kidney disease.
Search PubMed for Autosomal dominant tubulointerstitial kidney disease

Browse all Autosomal dominant tubulointerstitial kidney disease news →

Specialist Network

Top 6 by expertise

View all Autosomal dominant tubulointerstitial kidney disease specialists →

Quick Actions